Cargando…
Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation
Reconstructive transplantation has emerged as clinical reality over the past decade. Long-term graft acceptance has been feasible in extremity and facial vascularized composite allotransplantation (VCA) under standard immunosuppression. Minimizing overall burden of lifelong immunosuppression is key...
Autores principales: | Plock, Jan A., Schnider, Jonas T., Solari, Mario G., Zheng, Xin Xiao, Gorantla, Vijay S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719134/ https://www.ncbi.nlm.nih.gov/pubmed/23888159 http://dx.doi.org/10.3389/fimmu.2013.00175 |
Ejemplares similares
-
Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential
por: Schnider, Jonas T., et al.
Publicado: (2013) -
Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?
por: Plock, Jan A., et al.
Publicado: (2013) -
Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics
por: Feturi, Firuz G., et al.
Publicado: (2018) -
Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
por: Starzl, Ravi, et al.
Publicado: (2013) -
IGF-1 and Chondroitinase ABC Augment Nerve Regeneration after Vascularized Composite Limb Allotransplantation
por: Kostereva, Nataliya V., et al.
Publicado: (2016)